Brief: FDA Says Getinge Removes Vaporizer Sevoflurane Quick-Fil & Expands Recall Of Vaporizer Sevoflurane Maquet Filling
03/03/2025 19:08
March 3 (Reuters) - FDA: FDA: GETINGE REMOVES VAPORIZER SEVOFLURANE QUICK-FIL AND EXPANDS RECALL OF VAPORIZER SEVOFLURANE MAQUET FILLING FDA: GETINGE'S SOME VAPORIZER SEVOFLURANE MODELS REMOVED & RECALLED DUE TO RISK OF PATIENT & HEALTH CARE PROFESSIONAL EXPOSURE TO HYDROGEN FLUORIDE Further company coverage: [GETIb.ST] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Getinge publ AB
See all newsEurope Research Roundup: Akzo Nobel, Handelsbanken, RS Group
Medical gear maker Getinge beats Q3 profit estimates on pricing, product mix (updated)
Medical gear maker Getinge beats Q3 profit estimates on pricing, product mix
Sweden's Getinge Q3 organic sales rise 2.1%
Brief: Getinge Q3 Adjusted EBITA SEK 1,278 Million